MiddleBrook Pharmaceuticals, Inc. Retains Almac Pharma Services to Produce Physician Samples of MOXATAG(TM)

WESTLAKE, Texas, Feb. 4, 2009 (GLOBE NEWSWIRE) -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq:MBRK), a pharmaceutical company committed to developing anti-infective products that fulfill unmet medical needs, today announced that it has retained Almac Pharma Services(r) to provide packaging services for physician samples of MOXATAG (amoxicillin extended-release) Tablets, 775 mg. Almac Pharma Services(r) will work closely with MiddleBrook's chosen commercial manufacturer, STADA Production Ireland(r).